Ausgabe 3/2008
Inhalt (22 Artikel)
Candidate gene studies reveal that the WFS1 gene joins the expanding list of novel type 2 diabetes genes
J. Wasson, M. A. Permutt
Fatty acid-induced mitochondrial uncoupling in adipocytes is not a promising target for treatment of insulin resistance unless adipocyte oxidative capacity is increased
K. N. Frayn, D. Langin, F. Karpe
Exercise: the brittle cornerstone of type 2 diabetes treatment
S. F. E. Praet, L. J. C. van Loon
Can persistent organic pollutants explain the association between serum γ-glutamyltransferase and type 2 diabetes?
D.-H. Lee, M. W. Steffes, D. R. Jacobs Jr.
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes
J. Rosenstock, M. Davies, P. D. Home, J. Larsen, C. Koenen, G. Schernthaner
The effects of type 1 diabetes on cerebral white matter
K. Weinger, A. M. Jacobson, G. Musen, I. K. Lyoo, C. M. Ryan, D. C. Jimerson, P. F. Renshaw
Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes
M. L. Koivikko, M. Karsikas, P. I. Salmela, J. S. Tapanainen, A. Ruokonen, T. Seppänen, H. V. Huikuri, J. S. Perkiömäki
Pre-morbid intelligence, the metabolic syndrome and mortality: the Vietnam Experience Study
G. D. Batty, C. R. Gale, L. H. Mortensen, C. Langenberg, M. J. Shipley, I. J. Deary
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients
G. Targher, L. Bertolini, S. Rodella, G. Zoppini, G. Lippi, C. Day, M. Muggeo
Testing of diabetes-associated WFS1 polymorphisms in the Diabetes Prevention Program
J. C. Florez, K. A. Jablonski, J. McAteer, M. S. Sandhu, N. J. Wareham, I. Barroso, P. W. Franks, D. Altshuler, W. C. Knowler
Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations
P. W. Franks, O. Rolandsson, S. L. Debenham, K. A. Fawcett, F. Payne, C. Dina, P. Froguel, K. L. Mohlke, C. Willer, T. Olsson, N. J. Wareham, G. Hallmans, I. Barroso, M. S. Sandhu
USF1 gene variants contribute to metabolic traits in men in a longitudinal 32-year follow-up study
K. Auro, K. Kristiansson, B. Zethelius, C. Berne, L. Lannfelt, M.-R. Taskinen, M. Jauhiainen, M. Perola, L. Peltonen, A.-C. Syvänen
The association between the IFIH1 locus and type 1 diabetes
H.-Q. Qu, L. Marchand, R. Grabs, C. Polychronakos
Presence of functional cannabinoid receptors in human endocrine pancreas
F. J. Bermúdez-Silva, J. Suárez, E. Baixeras, N. Cobo, D. Bautista, A. L. Cuesta-Muñoz, E. Fuentes, P. Juan-Pico, M. J. Castro, G. Milman, R. Mechoulam, A. Nadal, F. Rodríguez de Fonseca
Autoantibodies to IA-2β improve diabetes risk assessment in high-risk relatives
P. Achenbach, E. Bonifacio, A. J. K. Williams, A. G. Ziegler, E. A. M. Gale, P. J. Bingley
Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS)
S. S. Soedamah-Muthu, N. Chaturvedi, J. C. Pickup, J. H. Fuller
Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study
M. Laakso, J. Zilinskaite, T. Hansen, T. Welløv Boesgaard, M. Vänttinen, A. Stančáková, P.-A. Jansson, F. Pellmé, J. J. Holst, T. Kuulasmaa, M. L. Hribal, G. Sesti, N. Stefan, A. Fritsche, H. Häring, O. Pedersen, U. Smith
Isoform-specific defects of insulin stimulation of Akt/protein kinase B (PKB) in skeletal muscle cells from type 2 diabetic patients
D. Cozzone, S. Fröjdö, E. Disse, C. Debard, M. Laville, L. Pirola, H. Vidal
Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy
D. M. Nathan, J. B. Buse, M. B. Davidson, E. Ferrannini, R. R. Holman, R. Sherwin, B. Zinman
Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations
P. W. Franks, O. Rolandsson, S. L. Debenham, K. A. Fawcett, F. Payne, C. Dina, P. Froguel, K. L. Mohlke, C. Willer, T. Olsson, N. J. Wareham, G. Hallmans, I. Barroso, M. S. Sandhu
Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus
A. Imagawa, T. Hanafusa, Y. Uchigata, A. Kanatsuka, E. Kawasaki, T. Kobayashi, A. Shimada, I. Shimizu, T. Maruyama, H. Makino